Loading...
Loading...
Contributors:
Dataset URI:
10.1371/journal.pone.0288077.t001PurposeTo identify the predictive role of pretreatment skeletal muscle mass index (SMI) for long-term survival of bladder cancer patients.MethodsSeveral databases were searched for studies investigating the relationship between pretreatment SMI and prognosis in bladder cancer. The overall survival (OS) and cancer-specific survival (CSS) were defined as primary and secondary outcomes, respectively. Hazard ratios (HRs) and 95% confidence intervals (CIs) were combined.ResultsNine studies involving 1476 cases were included. The results demonstrated that a lower pretreatment SMI was significantly related to poorer OS (HR = 1.56, 95% CI: 1.33–1.82, PConclusionLower pretreatment SMI was associated with worse long-term survival of bladder cancer patients.
Keyword(s):
33 &# 8211; 36 &# 8211; also obviously related; analysis; Biotechnology.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)